Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Nitrocontin 2.6## (strength format, wrong smpc)

Nitrocontin 2.6## (strength format, wrong smpc)

NAFDAC Reg. No. A4-7838 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 31 October 2026 · synced automatically from official sources.
Producto
Nitrocontin 2.6## (strength format, wrong smpc)
Número NAFDAC
A4-7838
Principio activo
Diluted Nitroglycerin
Dosis
2,6mg
Forma
Tablet
Tamaño del envase
1 x 25's (in polypropylene bottle)
Fabricante
No Constan
Solicitante (titular)
Phillips Pharmaceuticals (Nigeria) Limited
Approved
26 Apr 2023
Estado
Activo Ver en NAFDAC ↗
Registro válido hasta
25 Apr 2028
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Diluted nitroglycerin: uses, dosage and brands worldwide

Lo que encontramos

  • Nitrocontin 2.6## (strength format, wrong smpc) is on the NAFDAC register with an active registration (A4-7838). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Nitrocontin 2.6## (strength format, wrong smpc)

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Nitroglycerin sublingual tablets are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Nitroglycerin sublingual tablets are a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. ( 1 )

Cómo tomarlo y con qué frecuencia
  • Administer one tablet under the tongue or in the buccal pouch at the first sign of an acute anginal attack
  • Allow tablet to dissolve without swallowing
  • One additional tablet may be administered every 5 minutes until relief is obtained
  • No more than three tablets are recommended within a 15-minute period
  • If the pain persists after a total of 3 tablets in a 15-minute period, or if the pain is different than is typically experienced, seek prompt medical attention
  • Nitroglycerin sublingual tablets may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack
  • For patients with xerostomia, a small sip of water prior to placing the tablet under the tongue may help maintain mucosal hydration and aid dissolution of the tablet
  • Administer nitroglycerin sublingual tablets at rest, preferably in the sitting position. • At the onset of an attack, administer one tablet under the tongue or buccal pouch
  • One additional tablet may be administered every 5 minutes as needed
  • No more than 3 total tablets are recommended within a 15 minute period. • If chest pain persists after three tablets, seek prompt medical attention. • May be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack
Fortalezas en las que viene

Nitroglycerin Sublingual Tablets are supplied as white, round, flat-faced tablets in three strengths: 0.3 mg (Coded with “N” on one side and “3” on the other) 0.4 mg (Coded with “N” on one side and “4” on the other) 0.6 mg (Coded with “N” on one side and “6” on the other) Sublingual tablets, 0.3 mg; 0.4 mg; 0.6 mg ( 3 )

Infancia
  • The safety and effectiveness of nitroglycerin
  • In pediatric patients have not been established
Older adults

Clinical studies of nitroglycerin sublingual tablets did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. …

While you are taking it
  • Advise the patient to read the FDA-approved patient labeling (Patient Information)
  • GREENSTONE ® BRAND Distributed by: Greenstone LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc
  • GST:NITR:R1 Revised: 10/2024
Talk to a doctor first if

• Use of phosphodiesterase type 5 (PDE-5) inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulators. ( 4.1 , 7.1 ) • Severe anemia ( 4.2 ) • Increased intracranial pressure ( 4.3 ) • Hypersensitivity to nitroglycerin or to other nitrates or nitrites or any excipient ( 4.4 ) • Circulatory failure and shock ( 4.5 ) 4.1 PDE-5-Inhibitors and sGC-Stimulators Do not use nitroglycerin sublingual tablets in patients who are taking PDE-5 Inhibitors …

Medicines it may not mix with

Ergotamine: increased bioavailability of ergotamine. Avoid concomitant use. ( 7.2 ) 7.1 PDE-5-Inhibitors and sGC-Stimulators Nitroglycerin sublingual tablets are contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE-5). PDE-5-Inhibitors such as avanafil, sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates. Nitroglycerin sublingual tablets are contraindicated in patients who are taking soluble guanylate cyclase (sGC) stimulators. Concomitant use can cause hypotension. …

Warnings

• Tolerance: Excessive use may lead to tolerance. ( 5.1 ) • Hypotension: Severe hypotension may occur. ( 5.2 ) 5.1 Tolerance Excessive use may lead to the development of tolerance. Only the smallest dose required for effective relief of the acute angina attack should be used. A decrease in therapeutic effect of sublingual nitroglycerin may result from use of long-acting nitrates. 5.2 Hypotension Severe hypotension, particularly with upright posture, may occur with small doses of nitroglycerin particularly in patients with constrictive pericarditis, aortic or mitral stenosis, patients who may be volume-depleted, or are already hypotensive. …

Posibles efectos secundarios

The following adverse reactions are discussed in more detail elsewhere in the label: • Hypotension [see Warnings and Precautions (5.2) ] • Headache [see Warnings and Precautions (5.4) ] • Hypersensitivity [see Contraindications (4.4) ] Vertigo, dizziness, weakness, palpitation, and other manifestations of postural hypotension may develop occasionally, particularly in erect, immobile patients. Marked sensitivity to the hypotensive effects of nitrates (manifested by nausea, vomiting, weakness, diaphoresis, pallor, and collapse) may occur at therapeutic doses. Syncope due to nitrate vasodilatation has been reported. …

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary Limited published data on the use of nitroglycerin are insufficient to determine a drug associated risk of major birth defects or miscarriage. In animal reproduction studies, there were no adverse developmental effects when nitroglycerin was administered intravenously to rabbits or intraperitoneally to rats during organogenesis at doses greater than 64-times the human dose [see Data ] . …

If you take too much

10.1 Signs and Symptoms, Methemoglobinemia Nitrate overdosage may result in: severe hypotension, persistent throbbing headache, vertigo, palpitation, visual disturbance, flushing and perspiring skin (later becoming cold and cyanotic), nausea and vomiting (possibly with colic and even bloody diarrhea), syncope (especially in the upright posture), methemoglobinemia with cyanosis and anorexia, initial hyperpnea, dyspnea and slow breathing, slow pulse (dicrotic and intermittent), heart block, increased intracranial pressure with cerebral symptoms of confusion and moderate fever, paralysis and coma …

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-10-15.

Label for diluted nitroglycerin, the active ingredient registered with NAFDAC.

Check your pack of Nitrocontin 2.6## (strength format, wrong smpc)

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Nitrocontin 2.6## (strength format, wrong smpc)

What is in Nitrocontin 2.6## (strength format, wrong smpc)?

Nitrocontin 2.6## (strength format, wrong smpc) contains Diluted Nitroglycerin (2,6mg), as tablet, according to its NAFDAC registration record.

Is Nitrocontin 2.6## (strength format, wrong smpc) registered with NAFDAC?

Yes. Nitrocontin 2.6## (strength format, wrong smpc) is listed on the NAFDAC register under registration number A4-7838, and its registration is active as of 31 October 2026.

Has Nitrocontin 2.6## (strength format, wrong smpc) been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Nitrocontin 2.6## (strength format, wrong smpc) in our automatically synced alert list.

How can I check that my pack of Nitrocontin 2.6## (strength format, wrong smpc) is genuine?

Run a free authenticity scan with the NAFDAC number A4-7838, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Nitrocontin 2.6## (strength format, wrong smpc)?

Follow your prescription or the leaflet in your pack. The official label says: Administer one tablet under the tongue or in the buccal pouch at the first sign of an acute anginal attack. Allow tablet to dissolve without swallowing. One additional tablet may be administered every 5 minutes until relief is obtained. No more than three tablets are recommended within a 15-minute period. If the pain persists after a total of 3 tablets in a 15-minute period, or…

What is Nitrocontin 2.6## (strength format, wrong smpc) used for?

Nitroglycerin sublingual tablets are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Nitroglycerin sublingual tablets are a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. ( 1 ) (Summarised from the official U.S. FDA label for diluted nitroglycerin. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Nitrocontin 2.6## (strength format, wrong smpc)? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.